Skip to main content
. 2022 May 18;14(10):2486. doi: 10.3390/cancers14102486

Table 1.

Role of hENT1 expression on effectiveness of Gemcitabine and 5-FU/folinic-acid adjuvant therapy on overall survival in PDAC patients (Greenhalf et al.) [226].

Treatment High hENT1 (OS) Low hENT1 (OS)
Gemcitabine 26.2 months 17.1 months
5 FU/folinic acid 21.9 months 25.6 months